Targeting NEK2 as a promising therapeutic approach for cancer treatment
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting NEK2 as a promising therapeutic approach for cancer treatment
Authors
Keywords
-
Journal
CELL CYCLE
Volume 15, Issue 7, Pages 895-907
Publisher
Informa UK Limited
Online
2016-03-29
DOI
10.1080/15384101.2016.1152430
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cep68 can be regulated by Nek2 and SCF complex
- (2015) Xiaohui Man et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment
- (2015) Xiaoqi Liu Translational Oncology
- Nek2 activation of Kif24 ensures cilium disassembly during the cell cycle
- (2015) Sehyun Kim et al. Nature Communications
- Overexpression of NIMA-related kinase 2 is associated with progression and poor prognosis of prostate cancer
- (2015) Yan-Ru Zeng et al. BMC Urology
- NEK2 mediates ALDH1A1-dependent drug resistance in multiple myeloma
- (2015) Ye Yang et al. Oncotarget
- Inhibition of Hec1 as a novel approach for treatment of primary liver cancer
- (2014) Lynn YL Huang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Molecular Pathways: CDK4 Inhibitors for Cancer Therapy
- (2014) M. A. Dickson CLINICAL CANCER RESEARCH
- Nek2 and Plk4: prognostic markers, drivers of breast tumorigenesis and drug resistance
- (2014) Mihaela Marina Frontiers in Bioscience-Landmark
- Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1
- (2014) Lynn YL Huang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Discovery of 4-Aryl-N-arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties
- (2014) Ying-Shuan E. Lee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Overexpression of the Nek2 kinase in colorectal cancer correlates with beta-catenin relocalization and shortened cancer-specific survival
- (2014) Christopher P. Neal et al. JOURNAL OF SURGICAL ONCOLOGY
- TRF1 Ensures the Centromeric Function of Aurora-B and Proper Chromosome Segregation
- (2014) T. Ohishi et al. MOLECULAR AND CELLULAR BIOLOGY
- Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1
- (2014) Bertrade C. Mbom et al. MOLECULAR BIOLOGY OF THE CELL
- Activity of a Novel Hec1-Targeted Anticancer Compound against Breast Cancer Cell Lines In Vitro and In Vivo
- (2014) L. Y. L. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Novel small molecules disrupting Hec1/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism
- (2014) C-M Hu et al. ONCOGENE
- Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis
- (2014) Xinwen Zhong et al. TUMOR BIOLOGY
- Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer
- (2013) Yusuke Takahashi et al. ANNALS OF SURGICAL ONCOLOGY
- NEK2 phosphorylation antagonizes the microtubule stabilizing activity of centrobin
- (2013) Joonhyun Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
- (2013) Wen Zhou et al. CANCER CELL
- Cancerous Inhibitor of Protein Phosphatase 2A, an Emerging Human Oncoprotein and a Potential Cancer Therapy Target
- (2013) A. Khanna et al. CANCER RESEARCH
- Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells
- (2013) Jaehyung Lee et al. CELL CYCLE
- Mechanisms controlling the temporal degradation of Nek2A and Kif18A by the APC/C–Cdc20 complex
- (2013) Garry G Sedgwick et al. EMBO JOURNAL
- Cancerous Inhibitor of Protein Phosphatase 2A (CIP2A) Protein Is Involved in Centrosome Separation through the Regulation of NIMA (Never In Mitosis Gene A)-related Kinase 2 (NEK2) Protein Activity
- (2013) Ae Lee Jeong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Local Depletion of DNA Methylation Identifies a Repressive p53 Regulatory Region in theNEK2Promoter
- (2013) Nancy H. Nabilsi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation
- (2013) Thomas P Stricker et al. MODERN PATHOLOGY
- The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival
- (2013) C. Naro et al. NUCLEIC ACIDS RESEARCH
- Role of Nek2 on centrosome duplication and aneuploidy in breast cancer cells
- (2013) P Cappello et al. ONCOGENE
- Model system for irreversible inhibition of Nek2: thiol addition to ethynylpurines and related substituted heterocycles
- (2013) Honorine Lebraud et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Cdk4 and Nek2 Signal Binucleation and Centrosome Amplification in a Her2+ Breast Cancer Model
- (2013) Mary Kathryn Harrison Pitner et al. PLoS One
- Reconstruction of an Integrated Genome-Scale Co-Expression Network Reveals Key Modules Involved in Lung Adenocarcinoma
- (2013) Gholamreza Bidkhori et al. PLoS One
- Centrosomal kinase Nek2 cooperates with oncogenic pathways to promote metastasis
- (2013) T K Das et al. Oncogenesis
- 118 2-arylamino-6-ethynylpurines as Potent Irreversible Inhibitors of the Mitotic Kinase Nek2
- (2012) B. Carbain et al. EUROPEAN JOURNAL OF CANCER
- Gene expression signatures of angiocidin and darapladib treatment connect to therapy options in cervical cancer
- (2012) Martin Koch et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Cell cycle regulation by the NEK family of protein kinases
- (2012) A. M. Fry et al. JOURNAL OF CELL SCIENCE
- Design of Potent and Selective Hybrid Inhibitors of the Mitotic Kinase Nek2: Structure–Activity Relationship, Structural Biology, and Cellular Activity
- (2012) Paolo Innocenti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Post-translational modifications of TRF1 and TRF2 and their roles in telomere maintenance
- (2012) John R. Walker et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Plk1 Controls the Nek2A-PP1γ Antagonism in Centrosome Disjunction
- (2011) Balca R. Mardin et al. CURRENT BIOLOGY
- Abnormal expression of Nek2 and β-catenin in breast carcinoma: clinicopathological correlations
- (2011) Shuling Wang et al. HISTOPATHOLOGY
- Benzimidazole Inhibitors Induce a DFG-Out Conformation of Never in Mitosis Gene A-Related Kinase 2 (Nek2) without Binding to the Back Pocket and Reveal a Nonlinear Structure−Activity Relationship
- (2011) Savade Solanki et al. JOURNAL OF MEDICINAL CHEMISTRY
- Irreversible Nek2 Kinase Inhibitors with Cellular Activity
- (2011) Jeffrey C. Henise et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phosphorylation of the Ndc80 complex protein, HEC1, by Nek2 kinase modulates chromosome alignment and signaling of the spindle assembly checkpoint
- (2011) Randy Wei et al. MOLECULAR BIOLOGY OF THE CELL
- Tumor antigen analysis in neuroblastoma by serological interrogation of bioinformatic data
- (2010) M. Eric Kohler et al. CANCER SCIENCE
- Novel combination treatment for colorectal cancer using Nek2 siRNA and cisplatin
- (2010) Kazushi Suzuki et al. CANCER SCIENCE
- Aminopyrazine Inhibitors Binding to an Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization
- (2010) Daniel K. Whelligan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction
- (2010) Balca R. Mardin et al. NATURE CELL BIOLOGY
- Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells
- (2009) Ulrika Andréasson et al. AMERICAN JOURNAL OF HEMATOLOGY
- Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding
- (2009) Kyle A. Emmitte et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: A mechanism for aneuploidy in cancer
- (2009) Qingdu Liu et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Synthesis and Biological Evaluation of a Series of Novel Inhibitor of Nek2/Hec1 Analogues
- (2009) Xiao-Long Qiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Cdk2 and Cdk4 Regulate the Centrosome Cycle and Are Critical Mediators of Centrosome Amplification in p53-Null Cells
- (2009) A. M. Adon et al. MOLECULAR AND CELLULAR BIOLOGY
- Nip2/centrobin may be a substrate of Nek2 that is required for proper spindle assembly during mitosis in early mouse embryos
- (2009) Seongkeun Sonn et al. MOLECULAR REPRODUCTION AND DEVELOPMENT
- Small Molecule Targeting the Hec1/Nek2 Mitotic Pathway Suppresses Tumor Cell Growth in Culture and in Animal
- (2008) G. Wu et al. CANCER RESEARCH
- Nek2 as a novel molecular target for the treatment of breast carcinoma
- (2008) Nobuyuki Tsunoda et al. CANCER SCIENCE
- A Five-Gene Molecular Grade Index and HOXB13:IL17BR Are Complementary Prognostic Factors in Early Stage Breast Cancer
- (2008) X.-J. Ma et al. CLINICAL CANCER RESEARCH
- Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas
- (2008) Federica Barbagallo et al. JOURNAL OF PATHOLOGY
- The mitotic checkpoint kinase NEK2A regulates kinetochore microtubule attachment stability
- (2008) J Du et al. ONCOGENE
- -Catenin is a Nek2 substrate involved in centrosome separation
- (2007) S. Bahmanyar et al. GENES & DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now